Cargando…
Intracranial hemorrhage during administration of a novel oral anticoagulant
Objective: Oral anticoagulants are widely administered to patients with atrial fibrillation in order to prevent the onset of cardiogenic embolisms. However, intracranial bleeding during anticoagulant therapy often leads to fatal outcomes. Accordingly, the use of novel oral anticoagulants (NOACs), wh...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Japanese Association of Rural Medicine
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141379/ https://www.ncbi.nlm.nih.gov/pubmed/27928459 http://dx.doi.org/10.2185/jrm.2901 |